Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. USO
8. HOOD
9. DFTX
10. RGNX

Go back to Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

Taysha Gene Therapies (TSHA) Misses Q1 EPS by 24c

May 16, 2022 7:06 AM EDT

Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 EPS of ($1.31), $0.24 worse than the analyst estimate of ($1.07).

For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) click here.

... More